Direct demonstration of nitric oxide formation in organs of rabbits treated by transdermal glyceryl trinitrate using an in vivo spin trapping technique

2003 ◽  
Vol 17 (6) ◽  
pp. 709-715 ◽  
Author(s):  
Gaëlle Clermont ◽  
Sandrine Lecour ◽  
Catherine Vergely ◽  
Marianne Zeller ◽  
Caroline Perrin ◽  
...  
Circulation ◽  
1995 ◽  
Vol 92 (7) ◽  
pp. 1876-1882 ◽  
Author(s):  
Alexander Mülsch ◽  
Peter Mordvintcev ◽  
Eberhard Bassenge ◽  
Frank Jung ◽  
Bernd Clement ◽  
...  

1994 ◽  
Vol 113 (4) ◽  
pp. 1508-1514 ◽  
Author(s):  
Aman S. Hussain ◽  
Margo Poklewska-Koziell ◽  
James F. Brien ◽  
Gerald S. Marks ◽  
Kanji Nakatsu

1992 ◽  
Vol 70 (6) ◽  
pp. 935-937 ◽  
Author(s):  
Gerald S. Marks ◽  
Brian E. McLaughlin ◽  
Kanji Nakatsu ◽  
James F. Brien

Incubation of glyceryl trinitrate (GTN) with 5% (w/v) rat brain homogenate (RBH) resulted in biotransformation of the organic nitrate vasodilator drug to a mixture of glyceryl-1,2-dinitrate (1,2-GDN) and glyceryl-1,3-dinitrate (1,3-GDN). Heating of the RBH at 100 °C for 5 min and (or) pretreatment with 5 mM N-ethylmaleimide at 37 °C for 10 min demonstrated that about two-thirds of the GTN biotransformation activity was due to a sulfhydryl-dependent enzymatic process resulting in the predominant formation of 1,2-GDN, and that the remaining biotransformation activity was due to a sulfhydryl-dependent nonenzymatic process resulting in the selective formation of 1,3-GDN. In a preliminary experiment, nitric oxide formation was observed during the incubation of GTN with RBH under anaerobic conditions. These data support the idea that some of the therapeutic and adverse effects of GTN are mediated through its action in the central nervous system.Key words: glyceryl trinitrate, biotransformation, rat brain homogenate, sulfhydryl-dependent enzyme, nitric oxide formation.


1998 ◽  
Vol 25 ◽  
pp. S108
Author(s):  
Hong Sang ◽  
Yashige Kotake ◽  
Danny R. Moore ◽  
Lester A. Reinke ◽  
Toshihiko Ozawa

2010 ◽  
Vol 49 ◽  
pp. S14
Author(s):  
Jefferson Henrich Amaral ◽  
Marcelo Montenegro ◽  
Lucas Pinheiro ◽  
Graziele Ferreira ◽  
Jose Eduardo Tanus Santos

1992 ◽  
Vol 70 (2) ◽  
pp. 308-311 ◽  
Author(s):  
Gerald S. Marks ◽  
Brian E. McLaughlin ◽  
Kanji Nakatsu ◽  
James F. Brien

It has been proposed that the mechanism of the vasodilator action of glyceryl trinitrate (GTN) involves biotransformation to nitric oxide. A sensitive chemiluminescence method for nitric oxide determination was used to test this hypothesis. In four experiments, bovine pulmonary artery (BPA) was incubated with GTN (0.1 mM) in Krebs' solution (2 mL) containing 30 mM KCl, and in anaerobic conditions using 95% Ar – 5% CO2, in a sealed micro-Fernbach flask (6.2-mL volume). After incubation for 2, 5, 10, or 20 min at 37 °C, 400-μL aliquots of headspace gas were removed and injected into a redox chemiluminescence detector. Nitric oxide formation was first measurable at 5 min (76 ± 53 pmol/g wet wt. BPA), and increased with incubation time (174 ± 46 pmol/g wet wt. BPA after 10 min and 310 ± 67 pmol/g wet wt. BPA after 20 min). This is the first direct chemical measurement of nitric oxide formation during interaction of GTN with vascular smooth muscle. These data support the concept that GTN is a nitrovasodilator prodrug acting via the formation of nitric oxide.Key words: nitric oxide formation, glyceryl trinitrate, chemiluminescence, bovine pulmonary artery, vasodilation.


Sign in / Sign up

Export Citation Format

Share Document